Ischemic Heart Disease
Steal syndrome may be an adverse event in patients with a specific bypass graft
Published in Cardiovascular Week, November 15th, 2004
Scientists in Italy report, "There are only a few published studies on the association between subclavian steal syndrome and ischemic heart disease. The objective of this report is to evaluate the efficacy of subclavian stenoocclusion treatment in patients with subclavian steal syndrome (SSS) and previous coronary bypass."
F. Ferrara and colleagues of GESI in Rome explained, "Over the last 8 years we observed 207 patients who underwent left internal mammary artery-intraventricular...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2004-11-15)
More Articles from Cardiovascular Week
- Aortic Obstruction
Technique can be effective for complex or reoperative aortic obstruction - Atherosclerosis
Polymorphism in the L-PGDS gene contributes to carotid atherosclerosis - Cardiogenesis
GATA4 regulates cardiogenesis and is essential for proepicardium formation - Echocardiography
Exercise ECG provides information about risk for patients with suspected CAD - Natriuretic Peptides
N-BNP may reflect pulmonary capillary congestion in patients short of breath - ACE Inhibitors
Tissue-penetrating ACE inhibitor results in greater increase in NO production - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
